Presentation TVT 2013 Pharmacotherapy Alternatives During and After TAVR: Is There an Optimal Regimen? Presenter: Corrado Tamburino June 12, 2013
Presentation TVT 2013 An Anticoagulated Patient with Severe Paravalvular Regurgitation and Ostial Left Main Disease Presenter: Peter Pollak June 12, 2013
Presentation TVT 2013 Are Dedicated Transcutaneous LV Apical Access Closure Technologies Important to "Revive" the TA-TAVR Procedure? Presenter: Joerg Kempfert June 12, 2013
Presentation TVT 2013 The "Essential Primer" on Surgical Risk Scores: Key Take-home Messages Presenter: Todd Dewey June 12, 2013
Presentation TVT 2013 Frailty Predictors of Clinical Outcomes in TAVR Patients: Early Insights Presenter: Philip Green June 12, 2013
Presentation TVT 2013 Early Clinical Experiences with the Entourage TA-TAVR System Presenter: Raj Makkar June 12, 2013
Presentation TVT 2013 First-in-human case with a dedicated fully percutaneous TAVR system for pure aortic insufficiency Presenter: Marco Barbanti June 12, 2013